Alterity Therapeutics Limited
PRNAF
$0.01
$0.00-44.55%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.32% | -97.43% | -2.11% | 33.24% | 2.75% |
| Total Depreciation and Amortization | 0.53% | -12.09% | 1.90% | -10.97% | -2.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.31% | 450.19% | 2.13% | -46.16% | -2.74% |
| Change in Net Operating Assets | -0.32% | -343.28% | 2.12% | 166.87% | 2.75% |
| Cash from Operations | -0.32% | -250.88% | -2.11% | 64.40% | 2.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.32% | 202.14% | -2.12% | -- | -- |
| Cash from Investing | 0.32% | 202.14% | -2.12% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -12.59% | 0.00% | 13.78% | 0.00% |
| Issuance of Common Stock | 0.00% | -51.68% | 0.00% | 10,480.03% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 59.58% | 0.00% | -8,468.75% | 0.00% |
| Cash from Financing | 0.32% | -50.19% | 2.12% | 12,604.63% | -2.70% |
| Foreign Exchange rate Adjustments | -0.79% | 75.00% | -2.02% | -268.66% | 2.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.32% | -42.76% | 2.12% | 440.07% | 2.74% |